Concord Drugs Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹12.78Cr |
Net Profits | ₹0.24Cr |
Net Profit Margins | -1.88% |
Highlights
Revenue:
Concord Drugs Ltd’s revenue fell -5.54% since last year same period to ₹12.78Cr in the Q3 2023-2024. On a quarterly growth basis, Concord Drugs Ltd has generated 69.95% jump in its revenue since last 3-months.
Net Profits:
Concord Drugs Ltd’s net profit fell -153.33% since last year same period to ₹0.24Cr in the Q3 2023-2024. On a quarterly growth basis, Concord Drugs Ltd has generated -142.86% fall in its net profits since last 3-months.
Net Profit Margins:
Concord Drugs Ltd’s net profit margin fell -156.46% since last year same period to -1.88% in the Q3 2023-2024. On a quarterly growth basis, Concord Drugs Ltd has generated -125.22% fall in its net profit margins since last 3-months.
